NO20020131L - Diacylhydrazinderivater - Google Patents
DiacylhydrazinderivaterInfo
- Publication number
- NO20020131L NO20020131L NO20020131A NO20020131A NO20020131L NO 20020131 L NO20020131 L NO 20020131L NO 20020131 A NO20020131 A NO 20020131A NO 20020131 A NO20020131 A NO 20020131A NO 20020131 L NO20020131 L NO 20020131L
- Authority
- NO
- Norway
- Prior art keywords
- angioplasty
- fight
- arteriosclerosis
- restenosis
- thrombosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19932796A DE19932796A1 (de) | 1999-07-14 | 1999-07-14 | Diacylhydrazinderivate |
| PCT/EP2000/006307 WO2001005753A1 (de) | 1999-07-14 | 2000-07-05 | Diacylhydrazinderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20020131D0 NO20020131D0 (no) | 2002-01-11 |
| NO20020131L true NO20020131L (no) | 2002-03-12 |
Family
ID=7914676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020131A NO20020131L (no) | 1999-07-14 | 2002-01-11 | Diacylhydrazinderivater |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6649613B1 (pl) |
| EP (1) | EP1194401B1 (pl) |
| JP (1) | JP2003505365A (pl) |
| KR (1) | KR20020022773A (pl) |
| CN (1) | CN1210256C (pl) |
| AR (1) | AR024741A1 (pl) |
| AT (1) | ATE249427T1 (pl) |
| AU (1) | AU762350B2 (pl) |
| BR (1) | BR0012391A (pl) |
| CA (1) | CA2379041A1 (pl) |
| CZ (1) | CZ200219A3 (pl) |
| DE (2) | DE19932796A1 (pl) |
| DK (1) | DK1194401T3 (pl) |
| ES (1) | ES2206275T3 (pl) |
| HK (1) | HK1047085A1 (pl) |
| HU (1) | HUP0202371A3 (pl) |
| MX (1) | MXPA02000415A (pl) |
| NO (1) | NO20020131L (pl) |
| PL (1) | PL352966A1 (pl) |
| PT (1) | PT1194401E (pl) |
| SI (1) | SI1194401T1 (pl) |
| SK (1) | SK192002A3 (pl) |
| WO (1) | WO2001005753A1 (pl) |
| ZA (1) | ZA200201225B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10040105A1 (de) | 2000-08-17 | 2002-02-28 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften |
| DE10040103A1 (de) | 2000-08-17 | 2002-02-28 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II |
| FR2828884B1 (fr) * | 2001-08-27 | 2005-09-09 | Centre Nat Rech Scient | Hydrazinopeptoides et leurs utilisations dans le traitement des cancers |
| DE10209692A1 (de) * | 2002-03-06 | 2003-09-18 | Merck Patent Gmbh | Isochinolinderivate |
| DE10325049A1 (de) * | 2003-06-02 | 2004-12-23 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III |
| FR2859995A1 (fr) * | 2003-09-23 | 2005-03-25 | Centre Nat Rech Scient | Hydrazinopeptoides reduits et leurs utilisations dans le traitement des cancers |
| ES2450541T3 (es) | 2004-06-04 | 2014-03-25 | The Scripps Research Institute | Composiciones para el tratamiento de enfermedades neovasculares |
| US20060126018A1 (en) * | 2004-12-10 | 2006-06-15 | Junzhong Liang | Methods and apparatus for wavefront sensing of human eyes |
| CA2689137C (en) | 2007-05-29 | 2017-05-02 | Intrexon Corporation | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1361499A (en) | 1997-10-21 | 1999-05-10 | Merck & Co., Inc. | Azapeptide acids as cell adhesion inhibitors |
-
1999
- 1999-07-14 DE DE19932796A patent/DE19932796A1/de not_active Withdrawn
-
2000
- 2000-07-05 SK SK19-2002A patent/SK192002A3/sk unknown
- 2000-07-05 WO PCT/EP2000/006307 patent/WO2001005753A1/de not_active Application Discontinuation
- 2000-07-05 AT AT00947928T patent/ATE249427T1/de not_active IP Right Cessation
- 2000-07-05 CZ CZ200219A patent/CZ200219A3/cs unknown
- 2000-07-05 DE DE50003660T patent/DE50003660D1/de not_active Expired - Fee Related
- 2000-07-05 HU HU0202371A patent/HUP0202371A3/hu unknown
- 2000-07-05 CA CA002379041A patent/CA2379041A1/en not_active Abandoned
- 2000-07-05 MX MXPA02000415A patent/MXPA02000415A/es unknown
- 2000-07-05 SI SI200030260T patent/SI1194401T1/xx unknown
- 2000-07-05 AU AU61551/00A patent/AU762350B2/en not_active Ceased
- 2000-07-05 DK DK00947928T patent/DK1194401T3/da active
- 2000-07-05 EP EP00947928A patent/EP1194401B1/de not_active Expired - Lifetime
- 2000-07-05 US US10/030,691 patent/US6649613B1/en not_active Expired - Fee Related
- 2000-07-05 KR KR1020027000551A patent/KR20020022773A/ko not_active Application Discontinuation
- 2000-07-05 JP JP2001511414A patent/JP2003505365A/ja active Pending
- 2000-07-05 PL PL00352966A patent/PL352966A1/pl unknown
- 2000-07-05 ES ES00947928T patent/ES2206275T3/es not_active Expired - Lifetime
- 2000-07-05 PT PT00947928T patent/PT1194401E/pt unknown
- 2000-07-05 BR BR0012391-9A patent/BR0012391A/pt active Pending
- 2000-07-05 CN CNB008101477A patent/CN1210256C/zh not_active Expired - Fee Related
- 2000-07-14 AR ARP000103620A patent/AR024741A1/es unknown
-
2002
- 2002-01-11 NO NO20020131A patent/NO20020131L/no not_active Application Discontinuation
- 2002-02-13 ZA ZA200201225A patent/ZA200201225B/en unknown
- 2002-11-29 HK HK02108680.6A patent/HK1047085A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020022773A (ko) | 2002-03-27 |
| CN1360568A (zh) | 2002-07-24 |
| DE19932796A1 (de) | 2001-01-18 |
| AU762350B2 (en) | 2003-06-26 |
| DK1194401T3 (da) | 2004-08-16 |
| BR0012391A (pt) | 2002-03-19 |
| ES2206275T3 (es) | 2004-05-16 |
| CA2379041A1 (en) | 2001-01-25 |
| SI1194401T1 (en) | 2004-02-29 |
| DE50003660D1 (de) | 2003-10-16 |
| SK192002A3 (en) | 2002-06-04 |
| EP1194401A1 (de) | 2002-04-10 |
| CN1210256C (zh) | 2005-07-13 |
| US6649613B1 (en) | 2003-11-18 |
| MXPA02000415A (es) | 2002-07-30 |
| HUP0202371A2 (en) | 2002-10-28 |
| AR024741A1 (es) | 2002-10-23 |
| ATE249427T1 (de) | 2003-09-15 |
| EP1194401B1 (de) | 2003-09-10 |
| PT1194401E (pt) | 2004-02-27 |
| NO20020131D0 (no) | 2002-01-11 |
| WO2001005753A1 (de) | 2001-01-25 |
| HUP0202371A3 (en) | 2002-11-28 |
| HK1047085A1 (zh) | 2003-02-07 |
| AU6155100A (en) | 2001-02-05 |
| CZ200219A3 (cs) | 2002-04-17 |
| ZA200201225B (en) | 2003-07-30 |
| PL352966A1 (pl) | 2003-09-22 |
| JP2003505365A (ja) | 2003-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW372232B (en) | Phenylalanine derivatives | |
| NZ511927A (en) | Phenylglycine derivatives | |
| DK1259485T3 (da) | Benzamider og beslægtede inhibitorer for faktor Xa | |
| CA2280727A1 (en) | Bicyclic amino acids | |
| AR027398A1 (es) | Derivados de indol-3-ilo | |
| NO20020131L (no) | Diacylhydrazinderivater | |
| WO2001056989A3 (en) | Inhibitors of factor xa | |
| EP1213285A3 (en) | 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors | |
| CL2003002042A1 (es) | Compuestos derivados de 3,9-diazabiciclo[3.3.1]noneno; composicion farmaceutica; y uso del compuesto como inhibidor de renina (ras), para tratar hipertension, insuficiencia cardiaca congestiva, hipertension pulmonar, insuficiencia renal, ateroscleros | |
| RU94002323A (ru) | Производные пиперазинов, способ их получения, фармацевтическая композиция, способ ее получения и использования | |
| CA2348391A1 (en) | Chromenone and chromanone derivatives as integrin inhibitors | |
| WO2000048996A3 (de) | Beta-alaninderivate | |
| WO2001057021A3 (en) | 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa | |
| DE60221505D1 (de) | FAKTOR Xa BENZAMIDIN INHIBITOREN | |
| RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
| MD523G2 (ro) | Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
| PL361745A1 (pl) | Pochodne karbamidu i karbaminianu jako inhibitoryintegryny | |
| MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
| WO2002026720A3 (en) | PIPERAZINE BASED INHIBITORS OF FACTOR Xa | |
| BR0308195A (pt) | Derivados de isoquinolina | |
| HUP0301784A2 (hu) | Imidazol és benzimidazol bifenilszármazékai, alkalmazásuk, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények | |
| WO2001010841A3 (de) | Fluorenderivate als integrin inhibitoren | |
| HUP0202710A2 (hu) | Vitronektin receptor antagonisták, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| AR008717A1 (es) | Derivados de peptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, laspreparaciones farmaceuticas que los contienen y un procedimiento par obtener estas preparaciones farmaceuticas | |
| CA2185394A1 (en) | Biotinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |